Clinical trial Recruiting at 1 site Interventional Ages Any age to 1 Year

Does having allergic parents raise the chance of bronchiolitis in babies by 12 months?

Official title: Primary Allergy and Its Impact on the Occurrence of Respiratory Distress in Infants at 12 Months of Age

Run by Centre Hospitalier Universitaire, Amiens · NCT07832643 · Data updated 2026-11-12

We’re testing if infants with at least one allergic parent are more likely to have bronchiolitis by 12 months compared to infants whose parents have no allergies.

Quick facts

Study typeInterventional
AgesAny age to 1 Year
SexAll
Enrollment508 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens, Picardie)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedJuly 2027
Study endsJuly 2028
Registry record updatedSeptember 22, 2026
Trial IDNCT07832643 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants born at CHU Amiens Picardie at term (≥37 weeks) whose mothers can understand French and are enrolled in the social security system.

Probably not a fit

Infants without allergic parents or those who don’t develop bronchiolitis may not experience a direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will collect data via a parent questionnaire at 6 and 12 months to see if parental allergy status is linked to bronchiolitis in the first year. The study uses an observational-like questionnaire approach to explore early life respiratory outcomes in a defined term birth population at a single hospital in Amiens. Eligible infants are full‑term births born at CHU Amiens Picardie with mothers able to participate in French. Exclusion criteria include prematurity, multiple gestations, congenital malformations observed at birth, or parental refusal. The primary aim is to estimate the incidence of bronchiolitis by 12 months based on parental allergy history.

Why it matters

Potential benefit: If successful, results could help identify infants at higher risk for bronchiolitis and inform early monitoring or guidance for families.

How similar studies have gone: Previous work suggests parental allergy status can be linked to childhood allergic outcomes, but this exact birth‑cohort approach to bronchiolitis risk is less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Newborns delivered at Amiens Picardie University Hospital, Full-term newborns, i.e.,
* ≥ 37+0 weeks of gestation (SA),
* Newborns whose mothers are of legal age and capable of understanding, reading, and speaking French or, failing that, who have someone in their immediate circle capable of understanding, reading, and speaking French;
* Newborns whose mothers are enrolled in the social security system;

Exclusion Criteria:

* Premature newborns
* Newborns whose parents refused to allow them to participate in the study
* Newborns from multiple pregnancies
* Newborns with malformations diagnosed prenatally or immediately after birth (in the delivery room)

Where it's running

  • CHU Amiens Picardie
    Amiens, Picardie, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • What the Mayo Clinic is learning from blood clot tests in allergic reactions

    This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.

    Recruiting Mayo Clinic · Rochester, Minnesota · NCT07905911

  • Using alpha-gal KO pork to see if it reduces reactions in people with Alpha-gal Syndrome

    This study tests whether eating pork that lacks the alpha-gal allergen lowers reaction risk for people with Alpha-gal Syndrome, using a crossover design where each participant tries both KO and wild-type pork on separate days.

    Recruiting Phase 2 National Institute of Allergy and Infectious Diseases (NIAID) · Little Rock, Arkansas and 3 other locations · NCT07611435

  • Lymph node examination during cat allergy immunotherapy

    This project will test how lymph nodes react after a small cat allergen skin challenge in people with cat allergy who are either on long-term allergy shots or have never had immunotherapy.

    Recruiting Early Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · Boston, Massachusetts · NCT07447869

  • How classroom indoor air affects children's allergies and wellbeing

    This project will test whether continuous classroom and home air pollutant monitoring can identify pollution patterns linked to worse allergy or asthma symptoms in school-age children.

    Recruiting University Hospital, Montpellier · Montpellier · NCT07402200

  • Beltaven shots for allergy to honeybee, paper wasp, or yellow jacket

    This project will try subcutaneous Beltaven allergy shots in people aged 14 and up who have had systemic reactions to Apis mellifera, Polistes dominula, or Vespula stings to see if they are safe and helpful in routine care.

    Recruiting at 13 sites Probelte Pharma S.L.U. · Barcelona, Barcelona and 12 other locations · NCT07309822

  • Biomarkers that predict peanut allergy reactions during a feeding test

    This study tests whether biomarkers can predict which children and teens will react during a peanut oral food challenge.

    Recruiting at 8 sites National Institute of Allergy and Infectious Diseases (NIAID) · Little Rock, Arkansas and 9 other locations · NCT07279467

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.